Connection

JOSEPH JANKOVIC to Dopamine Antagonists

This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Dopamine Antagonists.
Connection Strength

4.400
  1. Drug-induced parkinsonism: diagnosis and treatment. Expert Opin Drug Saf. 2024 Dec; 23(12):1503-1513.
    View in: PubMed
    Score: 0.936
  2. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470.
    View in: PubMed
    Score: 0.542
  3. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs. 2016 May; 76(7):779-87.
    View in: PubMed
    Score: 0.520
  4. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord. 2014 Jan; 29(1):126-30.
    View in: PubMed
    Score: 0.437
  5. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother. 2010 Jun; 10(6):893-901.
    View in: PubMed
    Score: 0.345
  6. Tardive gait. Clin Neurol Neurosurg. 2008 Feb; 110(2):198-201.
    View in: PubMed
    Score: 0.289
  7. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. Arch Neurol. 2007 May; 64(5):676-82.
    View in: PubMed
    Score: 0.279
  8. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol. 2006 Mar; 3(3):138-48.
    View in: PubMed
    Score: 0.257
  9. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Mov Disord. 2018 08; 33(8):1272-1280.
    View in: PubMed
    Score: 0.153
  10. Tardive syndromes. J Neurol Sci. 2018 06 15; 389:35-42.
    View in: PubMed
    Score: 0.147
  11. Treatment options for chorea. Expert Rev Neurother. 2018 Jan; 18(1):51-63.
    View in: PubMed
    Score: 0.145
  12. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol. 1995 Jun; 18(3):197-214.
    View in: PubMed
    Score: 0.122
  13. Treatment of dystonia. Lancet Neurol. 2006 Oct; 5(10):864-72.
    View in: PubMed
    Score: 0.067
  14. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005 Jan; 20(1):86-9.
    View in: PubMed
    Score: 0.059
  15. Dystonia: medical therapy and botulinum toxin. Adv Neurol. 2004; 94:275-86.
    View in: PubMed
    Score: 0.055
  16. Tourette's syndrome. N Engl J Med. 2001 Oct 18; 345(16):1184-92.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.